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1. Introduction 
In recent years the compositions of the lipopoly 
saccharides of Gram-negative organisms, especially 
Salmonella species, have been studied extensively. 
As a result, there has emerged a general concept of 
the structures of these immunologically important 
macromolecules [ 11. The corresponding cell wall 
components of Vibrio cholerae have, however, re- 
ceived scant attention. This report presents preli- 
minary results concerning the composition of a 
lipopolysaccharide of Vibrio cholera 569B (Inaba). 
2. Methods and materials 
2.1. Preparation of materials 
Vibrio cholerae 569B (inaba) cells were grown on 
nutrient agar in Roux bottles at 37’ for 36 hr. The 
cells were harvested in saline, centrifuged at 10,000 g 
for 20 min, washed three times in saline and once with 
distilled water. After incubation in a solution of EDTA 
(0.005 M) in tris-HCl(O.12 M, pH 8.0) at 37” for 30 
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min [2] , the vibrios were again collected by centrifu- 
gation and extracted with 45% phenol by the method 
of Westphal and Jann [3] . The resultant lipopolysac- 
charide fraction was further purified by ultracentri- 
fugation of an aqueous solution (81,000 g 2 hr). The 
lipopolysaccharide product was obtained in approx. 
1% yield, based on dry weight of organisms. It was 
free from nucleic acid (lack of absorption at 260 nm). 
Cell-wall polysaccharide was prepared as by 
Freeman [4] and Lipid A as by Nowotny [5]. Lipo- 
polysaccharide was treated with periodate as by 
Nikaido [6]. Perseitol was purchased from Sigma 
Chemical Company. 
2.2. General analytical methods 
Neutral sugars were estimated by gas chromato- 
graphy of their alditol acetates [7] . The polysaccha- 
ride or lipopolysaccharide (2 to 5 mg) was treated 
with Dowex-50 (H’) in 0.01 N hydrochloric acid (1 ml) 
in a sealed fusion tube at 105”. Where appropriate, 
xylose was incorporated as an internal standard. 
Hydrolysis was complete in 7 days. The hydrolysate 
was passed through a short column of Dowex-1 
(HCO;) and treated with sodium borohydride in the 
usual way. Acetylation was achieved using sodium 
acetate/acetic anhydride at 120” for 2 hr. The excess 
anhydride was removed in a gentle stream of nitrogen 
and the acetates extracted into ether, filtered and the 
solution concentrated before examination by gas 
chromatography.(conditions 1). 
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The amino sugar, estimated by the modified 
Elson-Morgan procedure of Gatt and Berman [8], 
was shown to consist entirely of glucosamine by 
the amino acid analyser and by the method of 
Stoffyn and Jeanloz [9]. Uranic acid was estimated 
by the Dische carbazole method [lo] and 2-keto-3- 
deoxyoctonate (KDO) by that of Osborn [ 1 l] . Gly- 
cerol was detected by paper chromatography [ 121 
and estimated semi-quantitatively by gas chromato- 
graphy of the tribenzoate (conditions 2) [ 131 and 
the tris (trimethylsilyl) derivative (conditions 3) [ 141. 
Accurate quantitation by the enzymic procedure of 
Spinella and Mayer [ 151, was carried out on a 7-day 
Dowex-50 hydrolysates. Parallel runs demonstrated 
the lack of destruction of glycerol, as well as its 
quantitative release from glycerophosphate, under 
these conditions. Ethanolamine was detected by paper 
chromatography (system D) [ 161 and estimated semi- 
quantitatively by gas chromatography of its dibenzoate 
(conditions 2) and by the calorimetric procedure of 
Dittmer and Wells [16-181. The protein content of 
the preparations was determined by the Folin method 
[ 191 and the constituent amino acids by the Technicon 
system. Total fatty acids were estimated as by Dun- 
combe [20] using palmitic acid as standard and total 
phosphorus as by Ames [ 2 1 ] . Nitrogen and acetyl 
analyses were carried out by the Australian Microanaly- 
tical Service, Melbourne. 
Descending paper chromatography was carried out 
using Whatman No. 3 paper and (A) butanol-pyridine- 
water (6:4:3); (B) ethyl acetate-pyridine-water 
(8:2: 1); (C) ethyl acetate-pyridine-water (10:4:3) 
and (D) propanol-ethyl-acetate-water (7: 1:2). Sugars 
were detected with alkaline silver nitrate. 
2.3. Gas chromatography 
Analysis was carried out using a Varian Aerograph 
Model 1701. Silanized stainless steel tubing was used 
throughout and the carrier gas nitrogen. Conditions 
used were 1) column (2 m X 3 mm) packed with fluo- 
rinated silicone QF-1 (0.5%) and neopentylglycol 
succinate (0.5%) on Varaport 30 (1 OO/ 120 mesh). 
The oven temperature was raised from 180’ to 220’ 
at l”/min and the nitrogen flow rate was 20 ml/min; 
2) column (200 X 3 mm) packed with SE-30 (4%) 
on Varaport 30. The temperature was raised from 150’ 
to 250’ at lO’/min and the flow rate was 30 ml/min; 
3) columm (2 m X 3 mm) packed with SE-30 (3%) on 
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Table 1 
Typical analytical results for Vibrio cholera 569B 
lipopolysaccharide and cell-wall polysaccharide. 
Mannose% * 
Glucose% 
Heptose% 
Lipopoly. 
saccharide 
1.40 
6.69 
6.87 
Cell-wall 
polysaccharide 
3.6 
20.3 
6.2 / 
Glucosamine% * 6.1 
&lactose% * 0 
Glycerol% * 1.1 
Ethanolamine% * approx. 3 
Fatty acids% * 18.5 
Protein 2 
Lipid A% 30 
Total P% 2.2 
Total N% 2.7 
Ace tyl% 2.6 
Loss on drying ** 14 
* expressed as anhydro residues. 
** dried at 0.2 mm Hg, 70°, 30 hr. 
2 
0 
.- 
0 
4.1 
Varaport 30. The oven temperature was increased 
from 100” to 150’ at 2“/min and the flow rate was 
15 ml/min. 
2.4. Serological methods 
Passive haemagglutination was carried out as by 
Auzins [22] using alkali-treated LPS. Antiserum was 
prepared as by Neoh and Rowley [23] ; inhibition 
assays were carried out using 4 haemagglutinating 
doses of the antiserum. 
3. Results and discussion 
Many different procedures have been used to iso- 
late serologically active components from cell walls 
of Vibrio cholerae. These include phenol/water ex- 
traction [24] , treatment with mineral acid [26] , and 
ammonium sulphate fractionation [25]. Treatment 
of other Gram-negative bacteria with EDTA/tris HCl 
causes release of lipopolysaccharides [2] . Attempted 
preparation of cholera lipopolysaccharide by this 
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mild procedure gave erratic results: often no product 
was obtained. Subsequent extraction of the recovered 
vibrios with 45% phenol, however, led to a superior 
lipopolysaccharide, free from nucleic acid and agar. 
The gas chromatogam of the alditol acetates of 
the neutral sugars present in the lipopolysaccharide 
is extremely clean. Apart from glucose, mannose and 
heptose (see table l), only a trace amount of arabinose 
(approx. 0.1%) and a small unassigned peak (approx. 
l%), eluted closely after the glucose derivative, were 
noted. Galactose, previously reported as a component 
of cholera polysaccharide materials [24,26] is absent, 
while mannose and heptose, previously unrecognized, 
are clearly present. The heptose is believed to be L- 
glycero-D-manno-heptose (or its enantiomer) on the 
basis of its paper chromatographic behaviour. It has 
the expected mobility using solvent system A [29 ] . 
Using systems B and C, the component has R,-s 
identical to that of the main heptose of Salmonella 
typhimurium C5. Moreover, the corresponding alditol 
acetate has gas chromatographic behaviour identical 
to that of the corresponding Salmonella component 
as well as to that of authentic perseitol hepta-acetate. 
The occurrence of heptose as a component of a 
lipopolysaccharide is to be expected [l] . Mannose, 
however, may be present in a contaminant. Gas chro- 
matographic analyses of lipopolysaccharides of SaZmo- 
nella rough mutants constantly show traces of man- 
nose. The source of the sugar is by no means under- 
stood [30,3 l] . 
Our lipopolysaccharide differs in two other respects 
from previously described cholera materials: 1) The 
content of amino sugar is much lower and 2) uranic 
acid is absent. We have also carried out uranic acid 
estimations on whole vibrios and have been unable 
to detect this component. There is, however, strong, 
non-specific absorption at the wavelength used for the 
test and earlier workers may have been led to attribute 
this to the presence of uranic acid [24,26] . 
It will be noted that, by comparison with the 
lipopolysaccharide, the cell-wall polysaccharide is 
deficient in heptose. The mild conditions (0.2 M 
acetic acid, IOO”, 2 hr) used in the preparation of 
cell-wall polysaccharide are not expected to cause 
cleavage of pyranosidic linkages. Unless, therefore, 
heptose is involved in novel furanosidic bonding [32] , 
it is likely that at least some of the residues are linked 
by other labile bonds, e.g. phosphodiester bonds. 
Table 2 
Haemagglutination i hibition assays of 
polysaccharide preparations. 
inhibitor 
Amount to inhibit 4 HA doses 
(Ilg) 
Lipppolysaccharide 0.02 
Cell-wall polysaccharide 1.0 .- 2.0 
Periodate-treated 
lipopolysaccharide 
3.1-6.2 
This speculation may also be applied to glycerol, 
which is absent from the cell-wall polysaccharide. 
It is clear that we have not yet recognized all the 
constituents of our lipopolysaccharide. Indeed some 
30% of its weight is still unaccounted for. The possi- 
bility then exists that the immunologically most im- 
portant component still evades our attention. It is 
important to note, moreover, that the cell-wall poly- 
saccharide shows only l/50 of the haemagglutination 
inhibitory activity of the lipopolysaccharides (table 2). 
It would seem that an important antigenic determi- 
nant has been lost or destroyed during the acetic acid 
treatment. Heptose or glycerol may be implicated. 
The standard assay [ 1 l] for KDO is negative for 
both preparations. It is therefore necessary to postu- 
late a fundamentally different lipopolysaccharide strut 
ture from that of the Salmonella spp. where KDO is 
responsible for linking the polysaccharide and Lipid 
A moieties [ 1 I]. Galactose, a component of the usual 
‘core’ lipopolysaccharide [27] is also absent. 
The proportion of lipid in our lipopolysaccharide 
material is high. Initial studies have shown the pre- 
sence of glucosamine, phosphorus and a wide range 
of fatty acids in Lipid A, but no neutral sugars are 
present in this part of the complex. We tentatively 
propose a broad similarity of Lipid A of other species 
[ 1 ] . The results of the Folin protein assay and amino 
acid analysis are consistent. Surprisingly, the major 
amino acids are glycine and methionine. 
While the presence of glycerol and ethanolamine 
is unequivocal, their role is not entirely clear. The 
amino acid analyser has, however, shown the presen- 
ce of small amounts of phosphoethanolamine and 
glycerophosphoethanolamine in the acid hydrolysate 
(6 N HCl, 110’) 24 hr). A structural function for 
the components may therefore be suggested. Adams,. 
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Tornabene and Yaguchi [28] have recently reported 
isolation of glycerophosphoethanolamine from the 
lipopolysaccharide of Neisseria catarrhalis. 
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